AOP head of education, Dr Ian Beasley, took delegates on a journey down the “two-way street between vision and sleep” at 100% ...

The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit shares new consensus statements for the diagnosis and ...

Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ...

A self-reported electronic body map reveals that widespread pain is common in patients with chronic pancreatitis and ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

A Korean NHIS study of 3.8 million adults links longer diabetes duration to a modestly increased risk of pancreatic cystic neoplasms (PCN).

Novocure (NVCR) stock gains as the company's Tumor Treating Fields device hits the main goal in a mid-stage trial for ...

A recent Nature article on novel GLP-1 therapies underscores a truth few key opinion leaders in medicine like to focus on: ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance ...